Compare Diamondback Energy Inc (FANG) vs Kymera Therapeutics Inc. Common Stock (KYMR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Diamondback Energy Inc vs Kymera Therapeutics Inc. Common Stock — how do they compare? Diamondback Energy Inc trades at $197.66 (market cap $55.31B), while Kymera Therapeutics Inc. Common Stock trades at $105.11 (market cap $8.88B). The key difference: Diamondback Energy Inc is far larger — about 6.2× Kymera Therapeutics Inc. Common Stock's market cap, and Diamondback Energy Inc pays a 2.23% dividend while Kymera Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Diamondback Energy Inc for 70 Days and Kymera Therapeutics Inc. Common Stock for 0 Days on average.
| FANG | KYMR | |
|---|---|---|
Market Cap | $55.31B | $8.88B |
Volume | 2,808,399 | 1,028,790 |
Sector | Energy | Health |
52-Week High | $213.69 | $127.31 |
52-Week Low | $137.29 | $55.80 |
Typical Hold Time | 70 Days | 0 Days |
Enterprise Value | $67.46B | $8.27B |
Dividend Yield | 2.23% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Diamondback Energy (FANG) trades at $198.18, up 1.57% with strong technical momentum and bullish analyst sentiment. The stock shows robust earnings performance with recent quarterly beats and solid revenue growth from $14.93B in 2025 to projected $17.0B in 2026. Technical indicators show bullish moving averages while RSI levels suggest potential overbought conditions. The company maintains strong cash flow generation with $8.76B from operations in 2025 and recently announced a $1.10 dividend payment.
FANG presents a compelling growth opportunity with 90% analyst buy ratings and a $233.79 consensus price target offering 18% upside. However, declining profit margins from 45.84% in 2022 to 11.14% in 2025 and elevated P/E ratio of 37.75 warrant caution. Oil price volatility and insider selling activity represent key risks for investors considering entry at current levels near recent highs.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Diamondback Energy Inc
Diamondback Energy is an independent oil and gas producer in the United States. The company operates exclusively in the Permian Basin. At the end of 2021, the company reported net proven reserves of 1.8 billion barrels of oil equivalent. Net production averaged about 375,000 barrels per day in 2021, at a ratio of 60% oil, 20% natural gas liquids, and 20% natural gas.
Read more on FANG →About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →
